Ipca Labs

{
  "main_header": {
    "sid": 950228,
    "name": "Ipca Labs",
    "stock_name": "Ipca Labs",
    "full_name": "Ipca Laboratories Ltd",
    "name_url": "stocks-analysis/ipca-labs",
    "exchange": 1,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "1,435.30",
    "chg": -4.6,
    "chgp": "-0.32%",
    "dir": -1,
    "prev_price": "1,439.90",
    "mcapval": "36,706.00 Cr",
    "mcap": "Mid Cap",
    "scripcode": "524494",
    "symbol": "IPCALAB",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE571A01038",
    "curr_date": "Feb 03",
    "curr_time": "",
    "bse_nse_vol": "2.18 lacs",
    "exc_status": "Active",
    "traded_date": "Feb 03, 2026",
    "traded_date_str": "2026 02 03",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/ipca-labs-950228-1&utm_source=Spage_Header_Score",
    "mojoone": {
      "text": "Part of MojoOne Strategy",
      "type": "MS",
      "url": "https://www.marketsmojo.com/mojostocks#!#top10",
      "ismore": 0,
      "all_data": [],
      "is_blur": 1,
      "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/ipca-labs-950228-1&utm_source=Spage_Score_PartofStrategies"
    }
  },
  "news": {
    "results": [
      {
        "title": "Ipca Laboratories Ltd Technical Momentum Shifts Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/ipca-laboratories-ltd-technical-momentum-shifts-amid-mixed-market-signals-3815519",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/IpcaLaboratorie_technicaldot_3815519.png",
        "date": "2026-02-02 08:04:51",
        "description": "Ipca Laboratories Ltd, a key player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, moving from a bullish to a mildly bullish stance. Despite a recent decline in share price, the stock’s underlying technical indicators present a nuanced picture, reflecting both resilience and caution amid broader market volatility."
      },
      {
        "title": "Ipca Laboratories Gains 0.42%: Mixed Technical Signals Shape Weekly Momentum",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/ipca-laboratories-gains-042-mixed-technical-signals-shape-weekly-momentum-3812878",
        "imagepath": "",
        "date": "2026-01-31 14:04:16",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>Jan 27:</strong> Stock opens week at Rs.1,453.80, down 0.63% amid Sensex gains</p>\n                    <p><strong>Jan 28:</strong> Continued decline to Rs.1,447.90 despite Sensex rallying 1.12%</p>\n                    <p><strong>Jan 29:</strong> Technical downgrade to Buy by MarketsMOJO; stock rebounds 2.36% to Rs.1,482.10</p>\n                    <p><strong>Jan 30:</strong> Technical momentum shifts bullish; stock closes at Rs.1,469.25, down 0.87%</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.1,463.05</div></div>\n                    <div class=\"stat-it..."
      },
      {
        "title": "Ipca Laboratories Ltd Technical Momentum Shifts Signal Bullish Outlook",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/ipca-laboratories-ltd-technical-momentum-shifts-signal-bullish-outlook-3810640",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/IpcaLaboratorie_technicaldot_3810640.png",
        "date": "2026-01-30 08:02:12",
        "description": "Ipca Laboratories Ltd has exhibited a notable shift in its technical momentum, moving from a mildly bullish stance to a more confident bullish trend. This transition is underscored by a combination of technical indicators including MACD, RSI, moving averages, and Bollinger Bands, signalling renewed investor interest and potential upside in the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Ipca Laboratories Downgraded to Buy by MarketsMOJO Amid Mixed Technical Signals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/ipca-laboratories-downgraded-to-buy-by-marketsmojo-amid-mixed-technical-signals-3808864",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/IpcaLaboratorie_mojoScore_3808864.png",
        "date": "2026-01-29 08:10:09",
        "description": "Ipca Laboratories Ltd has seen its investment rating revised from Strong Buy to Buy, reflecting a nuanced shift in its technical outlook and valuation metrics despite robust financial performance. The downgrade, effective from 28 January 2026, follows a detailed reassessment across quality, valuation, financial trends, and technical indicators, signalling a more cautious stance amid evolving market dynamics."
      },
      {
        "title": "Ipca Laboratories Ltd Technical Momentum Shifts Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/ipca-laboratories-ltd-technical-momentum-shifts-amid-mixed-market-signals-3808761",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/IpcaLaboratorie_technicaldot_3808761.png",
        "date": "2026-01-29 08:02:25",
        "description": "Ipca Laboratories Ltd has experienced a subtle yet significant shift in its technical momentum, moving from a bullish to a mildly bullish stance as of late January 2026. Despite a slight dip in daily price, the stock’s technical indicators reveal a complex interplay of bullish and bearish signals, reflecting a nuanced market sentiment within the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Ipca Laboratories Ltd is Rated Strong Buy",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/ipca-laboratories-ltd-is-rated-strong-buy-3802950",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/IpcaLaboratorie_mojoScore_3802950.png",
        "date": "2026-01-24 10:10:39",
        "description": "Ipca Laboratories Ltd is rated Strong Buy by MarketsMOJO, with this rating last updated on 14 January 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 24 January 2026, providing investors with the most up-to-date insight into the company’s fundamentals, returns, and overall outlook."
      },
      {
        "title": "Why is Ipca Laboratories Ltd falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-ipca-laboratories-ltd-fallingrising-3802704",
        "imagepath": "",
        "date": "2026-01-24 00:50:09",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Recent Price Movement and Market Context</strong></p>\n<p>On 23 January, Ipca Laboratories’ stock price declined by ₹23.15, representing a 1.56% drop. The stock touched an intraday low of ₹1,455.20, marking a 2.05% decrease during the trading session. This underperformance was slightly worse than its sector peers, lagging by 0.48% on the day. Notably, the stock’s price remains above its 50-day, 100-day, and 200-day moving averages, indicating a longer-term uptrend, but it is currently trading below its 5-day and 20-day moving averages, signalling short-term weakness.</p>\n<p>Investor participation has also diminished, with delivery volumes on 22 January falling by over 52% compared to the five-day average. This decline in trading activity suggests reduced enthusiasm or caution among market par..."
      },
      {
        "title": "Ipca Laboratories Ltd Falls 2.73%: 3 Key Factors Driving the Weekly Decline",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/ipca-laboratories-ltd-falls-273-3-key-factors-driving-the-weekly-decline-3779628",
        "imagepath": "",
        "date": "2026-01-03 15:54:00",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>29 Dec 2025:</strong> Stock opens at ₹1,433.75, down 0.45% amid broader market weakness</p>\n                    <p><strong>30 Dec 2025:</strong> Sharp decline of 3.22% to ₹1,387.65 on increased volume</p>\n                    <p><strong>31 Dec 2025:</strong> Rebound with 2.62% gain to ₹1,424.05, outpacing Sensex</p>\n                    <p><strong>1 Jan 2026:</strong> Golden Cross formation announced; stock closes at ₹1,397.55 (-1.86%)</p>\n                    <p><strong>2 Jan 2026:</strong> MarketsMOJO upgrades rating to Buy; technical momentum shifts mildly bullish; stock closes at ₹1,401.00 (+0.25%)</p>\n                </div>\n\n                <div class=\"stats-row\">\n              ..."
      },
      {
        "title": "Ipca Laboratories Upgraded to Buy: Comprehensive Analysis of Quality, Valuation, Financial Trend and Technicals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/ipca-laboratories-upgraded-to-buy-comprehensive-analysis-of-quality-valuation-financial-trend-and-technicals-3778326",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/IpcaLaboratorie_mojoScore_3778326.png",
        "date": "2026-01-02 08:13:33",
        "description": "Ipca Laboratories Ltd has been upgraded from a Hold to a Buy rating, reflecting a notable improvement in its technical indicators alongside robust financial performance. The upgrade is underpinned by enhanced technical trends, solid quality metrics, attractive valuation, and positive financial momentum, signalling renewed investor confidence in this pharmaceutical sector stock."
      }
    ],
    "total": 904,
    "sid": "950228",
    "stock_news_url": "https://www.marketsmojo.com/news/ipca-laboratories-950228"
  },
  "announcements": [
    {
      "details": "IPCA Laboratories Limited has submitted to the Exchange a copy of Disclosure of Related Party Transactions pursuant to Regulation 23(9) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.",
      "source": "NSE",
      "caption": "IPCA Laboratories Limited - Other General Purpose",
      "datetime": "27-Nov-2019"
    },
    {
      "details": "IPCA Laboratories Limited has informed the Exchange regarding 'Update on US FDA'.",
      "source": "NSE",
      "caption": "IPCA Laboratories Limited - Updates",
      "datetime": "26-Nov-2019"
    },
    {
      "details": "IPCA Laboratories Limited has informed the Exchange regarding ' a Conference Call to discuss the Company's Q2 FY20 earnings and business update will be held on Friday, 8th November, 2019 at 11.00 hrs IST'.",
      "source": "NSE",
      "caption": "IPCA Laboratories Limited - Updates",
      "datetime": "04-Nov-2019"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "",
      "data": [
        {
          "title": "BOARD MEETING",
          "txt": "13 Feb 2026"
        }
      ]
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Ipca Laboratories Ltd has declared <strong>200%</strong> dividend, ex-date: 05 Aug 25",
          "dt": "2025-08-05",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Ipca Laboratories Ltd has announced <strong>1:2</strong> stock split, ex-date: 10 Jan 22",
          "dt": "2022-01-10",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Ipca Laboratories Ltd Technical Momentum Shifts Amid Mixed Market Signals

2026-02-02 08:04:51

Ipca Laboratories Ltd, a key player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, moving from a bullish to a mildly bullish stance. Despite a recent decline in share price, the stock’s underlying technical indicators present a nuanced picture, reflecting both resilience and caution amid broader market volatility.

Read full news article

Ipca Laboratories Gains 0.42%: Mixed Technical Signals Shape Weekly Momentum

2026-01-31 14:04:16

Key Events This Week

Jan 27: Stock opens week at Rs.1,453.80, down 0.63% amid Sensex gains

Jan 28: Continued decline to Rs.1,447.90 despite Sensex rallying 1.12%

Jan 29: Technical downgrade to Buy by MarketsMOJO; stock rebounds 2.36% to Rs.1,482.10

Jan 30: Technical momentum shifts bullish; stock closes at Rs.1,469.25, down 0.87%

Week Open

Rs.1,463.05

Read full news article

Ipca Laboratories Ltd Technical Momentum Shifts Signal Bullish Outlook

2026-01-30 08:02:12

Ipca Laboratories Ltd has exhibited a notable shift in its technical momentum, moving from a mildly bullish stance to a more confident bullish trend. This transition is underscored by a combination of technical indicators including MACD, RSI, moving averages, and Bollinger Bands, signalling renewed investor interest and potential upside in the Pharmaceuticals & Biotechnology sector.

Read full news article

Ipca Laboratories Downgraded to Buy by MarketsMOJO Amid Mixed Technical Signals

2026-01-29 08:10:09

Ipca Laboratories Ltd has seen its investment rating revised from Strong Buy to Buy, reflecting a nuanced shift in its technical outlook and valuation metrics despite robust financial performance. The downgrade, effective from 28 January 2026, follows a detailed reassessment across quality, valuation, financial trends, and technical indicators, signalling a more cautious stance amid evolving market dynamics.

Read full news article

Ipca Laboratories Ltd Technical Momentum Shifts Amid Mixed Market Signals

2026-01-29 08:02:25

Ipca Laboratories Ltd has experienced a subtle yet significant shift in its technical momentum, moving from a bullish to a mildly bullish stance as of late January 2026. Despite a slight dip in daily price, the stock’s technical indicators reveal a complex interplay of bullish and bearish signals, reflecting a nuanced market sentiment within the Pharmaceuticals & Biotechnology sector.

Read full news article

Ipca Laboratories Ltd is Rated Strong Buy

2026-01-24 10:10:39

Ipca Laboratories Ltd is rated Strong Buy by MarketsMOJO, with this rating last updated on 14 January 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 24 January 2026, providing investors with the most up-to-date insight into the company’s fundamentals, returns, and overall outlook.

Read full news article

Why is Ipca Laboratories Ltd falling/rising?

2026-01-24 00:50:09

Recent Price Movement and Market Context

On 23 January, Ipca Laboratories’ stock price declined by ₹23.15, representing a 1.56% drop. The stock touched an intraday low of ₹1,455.20, marking a 2.05% decrease during the trading session. This underperformance was slightly worse than its sector peers, lagging by 0.48% on the day. Notably, the stock’s price remains above its 50-day, 100-day, and 200-day moving averages, indicating a longer-term uptrend, but it is currently trading below its 5-day and 20-day moving averages, signalling short-term weakness.

Investor participation has also diminished, with delivery volumes on 22 January falling by over 52% compared to the five-day average. This decline in trading activity suggests reduced enthusiasm or caution among market par...

Read full news article

Ipca Laboratories Ltd Falls 2.73%: 3 Key Factors Driving the Weekly Decline

2026-01-03 15:54:00

Key Events This Week

29 Dec 2025: Stock opens at ₹1,433.75, down 0.45% amid broader market weakness

30 Dec 2025: Sharp decline of 3.22% to ₹1,387.65 on increased volume

31 Dec 2025: Rebound with 2.62% gain to ₹1,424.05, outpacing Sensex

1 Jan 2026: Golden Cross formation announced; stock closes at ₹1,397.55 (-1.86%)

2 Jan 2026: MarketsMOJO upgrades rating to Buy; technical momentum shifts mildly bullish; stock closes at ₹1,401.00 (+0.25%)

...

Read full news article

Ipca Laboratories Upgraded to Buy: Comprehensive Analysis of Quality, Valuation, Financial Trend and Technicals

2026-01-02 08:13:33

Ipca Laboratories Ltd has been upgraded from a Hold to a Buy rating, reflecting a notable improvement in its technical indicators alongside robust financial performance. The upgrade is underpinned by enhanced technical trends, solid quality metrics, attractive valuation, and positive financial momentum, signalling renewed investor confidence in this pharmaceutical sector stock.

Read full news article

View All News